PTK2B and neoplasm: A study by Hu et al. demonstrated a reduction in tumor weight and volume upon treatment with PF-562271 in established osteosarcoma xenograft tumors [41], supporting the notion that FAK and Pyk2 are important modulators of invasive and proliferative properties in tumor cells.